Bates SE - Search Results

1

Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells.

Ujhelly O, Ozvegy C, Várady G, Cervenak J, Homolya L, Grez M, Scheffer G, Roos D, Bates SE, Váradi A, Sarkadi B, Német K. Ujhelly O, et al. Among authors: bates se. Hum Gene Ther. 2003 Mar 1;14(4):403-12. doi: 10.1089/104303403321209005. Hum Gene Ther. 2003. PMID: 12659681 No abstract available.

2

Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.

Ozvegy C, Litman T, Szakács G, Nagy Z, Bates S, Váradi A, Sarkadi B. Ozvegy C, et al. Biochem Biophys Res Commun. 2001 Jul 6;285(1):111-7. doi: 10.1006/bbrc.2001.5130. Biochem Biophys Res Commun. 2001. PMID: 11437380

3

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

van der Kolk DM, Vellenga E, Scheffer GL, Müller M, Bates SE, Scheper RJ, de Vries EG. van der Kolk DM, et al. Among authors: bates se. Blood. 2002 May 15;99(10):3763-70. doi: 10.1182/blood.v99.10.3763. Blood. 2002. PMID: 11986234 Free article.

4

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, Sarkadi B, Bates SE. Morisaki K, et al. Among authors: bates se. Cancer Chemother Pharmacol. 2005 Aug;56(2):161-72. doi: 10.1007/s00280-004-0931-x. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838659

5

The role of breast cancer resistance protein in acute lymphoblastic leukemia.

Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG. Plasschaert SL, et al. Among authors: bates se. Clin Cancer Res. 2003 Nov 1;9(14):5171-7. Clin Cancer Res. 2003. PMID: 14613996

6

Arginine 383 is a crucial residue in ABCG2 biogenesis.

Polgar O, Ediriwickrema LS, Robey RW, Sharma A, Hegde RS, Li Y, Xia D, Ward Y, Dean M, Ozvegy-Laczka C, Sarkadi B, Bates SE. Polgar O, et al. Among authors: bates se. Biochim Biophys Acta. 2009 Jul;1788(7):1434-43. doi: 10.1016/j.bbamem.2009.04.016. Epub 2009 May 3. Biochim Biophys Acta. 2009. PMID: 19406100 Free PMC article.

7

Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.

Polgar O, Ozvegy-Laczka C, Robey RW, Morisaki K, Okada M, Tamaki A, Koblos G, Elkind NB, Ward Y, Dean M, Sarkadi B, Bates SE. Polgar O, et al. Among authors: bates se. Biochemistry. 2006 Apr 25;45(16):5251-60. doi: 10.1021/bi0521590. Biochemistry. 2006. PMID: 16618113 Free PMC article.

8

The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.

Macalou S, Robey RW, Jabor Gozzi G, Shukla S, Grosjean I, Hegedus T, Ambudkar SV, Bates SE, Di Pietro A. Macalou S, et al. Among authors: bates se. Cell Mol Life Sci. 2016 May;73(9):1927-37. doi: 10.1007/s00018-015-2118-5. Epub 2015 Dec 26. Cell Mol Life Sci. 2016. PMID: 26708291 Free PMC article.

9

Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.

Brendel C, Scharenberg C, Dohse M, Robey RW, Bates SE, Shukla S, Ambudkar SV, Wang Y, Wennemuth G, Burchert A, Boudriot U, Neubauer A. Brendel C, et al. Among authors: bates se. Leukemia. 2007 Jun;21(6):1267-75. doi: 10.1038/sj.leu.2404638. Epub 2007 Mar 22. Leukemia. 2007. PMID: 17519960

10

Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1).

Honjo Y, Morisaki K, Huff LM, Robey RW, Hung J, Dean M, Bates SE. Honjo Y, et al. Among authors: bates se. Cancer Biol Ther. 2002 Nov-Dec;1(6):696-702. doi: 10.4161/cbt.322. Cancer Biol Ther. 2002. PMID: 12642696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page